President Trump has issued an Executive Order regarding the onshoring of medical supply sourcing that requires federal authorities to “limit competition to only Essential Medicines, Medical Countermeasures, and Critical Inputs that are produced in the United States”. That comes in the wake of a struggle to secure resources from overseas in the wake of COVID-19. Panjiva’s data shows that while total medical supply imports increased by 2.7% in June versus May there was an 8.6% drop in PPE shipments and a 7.8% slide in pharmaceuticals. The PPE downturn likely continued in July with shipment...